Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 41 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 10677801

    Diagnosis and treatment of breast cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  2. US 10675304

    Combination immunotherapies for treatment of cancer

    PrimeVax Immuno-Oncology · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  3. US 10675272

    Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  4. US 10675258

    Method of using gamma-hydroxybutyrate compositions for the treatment of disorders

    Jazz Pharmaceuticals Ireland Limited · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  5. US 10676452

    Compound for the prophylaxis or treatment of organ damage

    Sulfateq B.V. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  6. US 10668055

    Cancer treatment using combinations of ERK and RAF inhibitors

    Biomed Valley Discoveries, Inc. · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  7. US 10668062

    Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes

    Lixte Biotechnology, Inc. · Granted Jun 2, 2020 · Expires May 28, 2040

    granted
  8. US 10662244

    Methods for tumor treatment using CD3XCD20 bispecific antibody

    REGENERON PHARMACEUTICALS, INC. · Granted May 26, 2020 · Expires May 21, 2040

    granted
  9. US 10662425

    Materials and methods for treatment of autosomal dominant retinitis pigmentosa

    CRISPR THERAPEUTICS AG · Granted May 26, 2020 · Expires May 21, 2040

    granted
  10. US 10660923

    Sinusitis diagnostics and treatments

    The Regents of the University of California · Granted May 26, 2020 · Expires May 21, 2040

    granted
  11. US 10663473

    Method of identifying a status of a mucosal intestinal epithelial barrier to improve treatment of inflammatory bowel disease

    Maximus Diagnostic Technologies LLC · Granted May 26, 2020 · Expires May 21, 2040

    granted
  12. US 10660889

    Compounds for treatment of cancer

    Curegenix, Inc. · Granted May 26, 2020 · Expires May 21, 2040

    granted
  13. US 10653743

    Methods for the treatment of depression and anxiety by a melanocortin 5 receptor antagonist, PG-20N

    Arizona Board of Regents on Behalf of the University of Arizona · Granted May 19, 2020 · Expires May 14, 2040

    granted
  14. US 10654916

    Compositions and methods for the treatment of neuromyelitis optica

    THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION · Granted May 19, 2020 · Expires May 14, 2040

    granted
  15. US 10653755

    Compositions and methods for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted May 19, 2020 · Expires May 14, 2040

    granted
  16. US 10655183

    Carcinoma diagnosis and treatment based on ODC1 genotype

    Arizona Board of Regents on Behalf of the University of Arizona · Granted May 19, 2020 · Expires May 14, 2040

    granted
  17. US 10653689

    Combination-based treatment method

    Nektar Therapeutics · Granted May 19, 2020 · Expires May 14, 2040

    granted
  18. US 10653665

    Method of treatment

    VANDA PHARMACEUTICALS INC. · Granted May 19, 2020 · Expires May 14, 2040

    granted
  19. US 10653652

    Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and (S)-3-amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic acid in the treatment of tinnitus, acute sensorineural hearing loss, meniere'S disease, tourette'S syndrome, attention deficit hyperactivity disorder and addiction

    OVID THERAPEUTICS INC. · Granted May 19, 2020 · Expires May 14, 2040

    granted
  20. US 10646523

    Combination comprising spirulina and palmitoylethanolamide and/or salts or pharmaceutically acceptable derivatives thereof and their formulations, for use in the prevention and/or in the treatment of hyperactivated tissue conditions

    AGAIN LIFE ITALIA SRL · Granted May 12, 2020 · Expires May 7, 2040

    granted
  21. US 10640493

    Phthalazine derivatives as inhibitors of PARP1, PARP2, and/or tubulin useful for the treatment of cancer

    The Regents of the University of California · Granted May 5, 2020 · Expires Apr 30, 2040

    granted
  22. US 10633657

    Methods for treatment of polycystic kidney disease

    The Board of Regents of the University of Texas System · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted
  23. US 10632209

    ASH1L inhibitors and methods of treatment therewith

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted
  24. US 10624959

    Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria

    The Regents of the University of Colorado, a Body Corporate · Granted Apr 21, 2020 · Expires Apr 16, 2040

    granted